The 2015 Tissue Engineering & Regenerative Medicine International Society World Congress accepted InVivo's presentation.
Here are three key notes:
1. The presentation is titled "Biodegradable Neuro-Spinal Scaffold Preserves Macroscopic Spinal Cord Architecture and Allows for Neural Regeneration at the Spinal Cord Contusion Epicenter."
2. Alex Aimetti, PhD, senior director, medical education and scientific support, is giving the presentation. The abstract is co-authored by Aimetti Richard Layer, PhD, Simon Moore, PhD, and Thomas Ulich, MD.
3. The Neuro-Spinal Scaffold is designed for acute spinal cord injury and is designed to act as a physical substrate for nerve sprouting. The scaffold is an investigational device with a Humanitarian Use Device designation currently being studied in an Investigational Device Exemption pilot.
"Making meaningful significant progress in the treatment of spinal cord injury continues to be our core mission at InVivo," said Mark Perrin, InVivo's CEO and Chairman. "This progress remains the future value driver for our company and I look forward to reporting on further achievements made by our scientific and clinical teams."